Evaluation of the Effectiveness of Nonsparticle-Rated Frequisences: Delivery Formed in Preventing Proteins Labor

Preterm labor (PTL), defined as labor occurring before 37 weeks of gestation, remains one of the leading causes of neonatal morbidity and mortality worldwide. Progesterone has been established as an effective treatment for preventing preterm birth, particularly in women with a history of spontaneous preterm delivery. However, the conventional methods of progesterone administration, such as intramuscular injections and vaginal suppositories, often face limitations in terms of bioavailability, patient compliance, and side effects. Nanoparticle-based drug delivery systems offer a promising alternative for overcoming these limitations by improving the bioavailability and controlled release of progesterone. This study aims to evaluate the effectiveness of nanoparticle-based progesterone delivery formats in preventing preterm labor. The study will assess various types of nanoparticle carriers, including liposomes, solid lipid nanoparticles (SLNs), and polymeric nanoparticles, in their ability to deliver progesterone efficiently and maintain therapeutic levels. Additionally, the pharmacokinetics, safety profile, and clinical outcomes of these nanoparticle formulations will be analyzed to determine their potential as a new therapeutic approach for preventing preterm labor.